Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study.

< BACK TO ARCHIVE


2022


Rheumatol Adv Pract


http://www.ncbi.nlm.nih.gov/pubmed/35591903?dopt=Abstract


6


2

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study.

Authors

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study.
Muller S, Hider SL, Singh Sokhal B, Lawton SA, Helliwell T, Mallen CD
Rheumatol Adv Pract. 2022; 6(2):rkac034.
PMID: 35591903.

Abstract

PMR is a common inflammatory condition in older adults, characterized by bilateral hip and shoulder pain and stiffness. Reducing oral glucocorticoids, classically used for ≤2 years, are the mainstay of treatment. This study considers the factors early in the disease course that might be associated with prolonged treatment.
Read This Paper